The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Gabapentin, Estrogen, and Placebo for Treating Hot Flushes: A Randomized Controlled Trial
Abstract
OBJECTIVE: To compare the efficacy of gabapentin, estrogen, and placebo in the treatment of hot flushes. METHODS: We performed a randomized, double-blind, placebo-controlled trial of 60 postmenopausal women to assess the efficacy of estrogen and gabapentin in the treatment of moderate-to-severe hot flushes. Participants were randomly assigned to receive either 0.625 mg/d of conjugated estrogens (n = 20), placebo (n = 20), or gabapentin titrated to 2,400 mg/d (n = 20) for 12 weeks. Participants recorded frequency and severity of baseline hot flushes on a hot flush diary for 2 weeks before randomization and for 12 weeks after randomization. The primary outcome measure was the weekly hot flush composite score, which takes into account both severity and frequency of hot flushes. Secondary outcome measures were differences in pre- and posttreatment scores pertaining to depression (Zung Depression Scale) and other climacteric symptoms (Greene Climacteric Scale). RESULTS: Intention-to-treat analysis showed that the reduction in the hot flush composite score for both estrogen (72%, P = .016) and gabapentin (71%, P = .004) was greater than the reduction associated with placebo (54%) at the conclusion of the 12th week. The extent of reduction in hot flush composite score, however, was not significantly different between estrogen and gabapentin (P = .63). No differences were seen between groups in the Zung Depression Scale, or in any of the Greene Climacteric subscales except for the Somatic Symptom cluster, which was significantly greater in the gabapentin arm than in the placebo arm. Despite a lack of group differences in adverse events, the Headache, Dizziness, and Disorientation cluster appeared with greater frequency in the gabapentin group. Estimation of the number needed to harm in this cluster suggests that these symptoms may occur with every fourth patient treated with gabapentin. CONCLUSION: Despite the small scale of this study, gabapentin appears to be as effective as estrogen in the treatment of postmenopausal hot flushes. CLINICAL TRIAL REGISTRATION: Clinicaltrials.gov, NCT 00276081. LEVEL OF EVIDENCE: I.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
A self-rating depression scale
ZUNG, W. W. K. (1965) · Archives of General Psychiatry · doi:10.1001/archpsyc.1965.01720310065008 · Cited by 9,813 · cited 1×
“70) Hot flushes due to natural menopause 16 (84)* 17 (89)* 19 (95) Hot flush severity Moderate 14 (78)† 12 (63)* 17 (85) Severe 4 (22)† 7 (37)* 3 (15) Currently treated for hot flushes (Yes) 1 (5)* 3 (19)* 3 (15) On any other medications? (Yes) 13 (75)† 15 (75) 12 (75)‡ Estrogen within the last 2 months? (Yes) 1 (5) 0…”
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Vestergaard, P., Hermann, A. P., Stilgren, L., Tofteng, C. L., Sørensen, O. H., Eiken, P., Nielsen, S. P., & Mosekilde, L. (2003) · Maturitas · doi:10.1016/s0378-5122(03)00181-6 · Cited by 60
Cited by
2016 IMS Recommendations on women’s midlife health and menopause hormone therapy
Baber, R. J., Panay, N., & Fenton, A. (2016) · Climacteric · doi:10.3109/13697137.2015.1129166 · Cited by 964
Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline
Stuenkel, C. A., Davis, S. R., Gompel, A., Lumsden, M. A., Murad, M. H., Pinkerton, J. V., & Santen, R. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2236 · Cited by 884
Nelson, H. D. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60346-3 · Cited by 729
The 2023 nonhormone therapy position statement of The North American Menopause Society
(2023) · Menopause · doi:10.1097/gme.0000000000002200 · Cited by 309
Metadata
- Authors
- Reddy, S. Y., Warner, H., Guttuso, T., Messing, S., DiGrazio, W., Thornburg, L., & Guzick, D. S.
- Venue
- Obstetrics & Gynecology
- Published
- 2006-07
- Volume
- 108
- Issue
- 1
- Pages
- 41-48
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W2329573779
- Cited by
- 223
- References
- 4
- FWCI
- 10.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gabapentin, Estrogen, and Placebo for Treating Hot Flushes: A Randomized Controlled Trial. https://app.cochat.ai/papers/10.1097/01.aog.0000222383.43913.ed
- The paper
- Reddy, S. Y., Warner, H., Guttuso, T., Messing, S., DiGrazio, W., Thornburg, L., & Guzick, D. S. (2006). Gabapentin, Estrogen, and Placebo for Treating Hot Flushes: A Randomized Controlled Trial. Obstetrics & Gynecology. https://doi.org/10.1097/01.aog.0000222383.43913.ed
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.